Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Immunome granted inducement stock options to four new employees under its 2024 Inducement Plan. Each option carries an exercise price of $27.07, matching the closing price on September 1, 2026, and vests over four years.
Key figures
- Exercise Price
- 27.07
- Shares Granted
- 86500
- Vesting Schedule
- 4 years (25% on 1-year anniversary, remainder monthly over 36 months)
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.